<DOC>
	<DOC>NCT02019849</DOC>
	<brief_summary>Twelve months follow-up of implant survival and clinical and radiological follow-up of Plasmafit® Cup.</brief_summary>
	<brief_title>Post Market Clinical Follow-Up of Plasmafit® Cup</brief_title>
	<detailed_description />
	<criteria>Minimum age 18 years Indication for cementless total hip arthroplasty Patient consent for study participation Physical and mental willingness to participate at clinical and radiological followup Patient not available for followup Increased anesthetics risks according to the "American Society of Anesthesiology": ASA IV Tumor Alcohol or drug abuse Permanent cortisone therapy Clinically relevant infection Pregnancy or planned pregnancy Prior interventions like osteotomy, fracture treatment or prior THA at the concerned hip Acute fracture at the concerned hip Patients needing a cemented hip arthroplasty</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>THA, Plasmafit®</keyword>
</DOC>